We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Blame Over Fosamax Draws Sharp Debate

Law360 (June 14, 2007, 12:00 AM EDT) -- The battle may be shaping up to be one of David and Goliath proportions, but for Ramon Harrison and hundreds of others like him, the chance to take Merck & Co. to task over its osteoporosis drug Fosamax is well worth the risk.

While Merck may already have its hands full trying to fend off thousands of Vioxx suits, another front has opened up in the pharmaceutical giant's product liability war as accusations fly that Fosamax actually leads to jaw deterioration.

Harrison, who took Fosamax for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.